サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1699444

抗ヒスタミン薬の世界市場：薬剤クラス別、剤形別、適応症別、投与経路別、タイプ別、流通チャネル別、地域別

Global Antihistamine Drugs Market, By Drug Class, By Form, By Indication, By Route of Administration, By Type, By Distribution Channel, By Geography

出版日
ページ情報
英文 155 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
抗ヒスタミン薬の世界市場：薬剤クラス別、剤形別、適応症別、投与経路別、タイプ別、流通チャネル別、地域別
出版日: 2025年02月21日
発行: Coherent Market Insights
ページ情報: 英文 155 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の抗ヒスタミン薬市場は、2025年には1,017億4,000万米ドルと推定され、2032年までには1,678億米ドルに達すると予測され、2025年から2032年にかけて7.4%のCAGR（複合年間成長率）で成長すると予測されています。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 1,017億4,000万米ドル
実績データ 2020年～2024年 予測期間 2025年～2032年
予測期間：2025年～2032年 CAGR： 7.40% 2032年の金額予測 1,678億米ドル
図.抗ヒスタミン薬の世界市場シェア（%）、地域別（2025年）
Global Antihistamine Drugs Market-IMG1

抗ヒスタミン薬は、くしゃみ、かゆみ、鼻水、涙目などのアレルギー症状の治療に用いられる薬剤の一種です。これらの薬剤は、アレルギー反応の際に放出される体内物質であるヒスタミンの働きを阻害することで効果を発揮します。抗ヒスタミン薬には主に2つのタイプがあります：第一世代抗ヒスタミン薬と第二世代抗ヒスタミン薬です。抗ヒスタミン薬は市販薬と処方薬があり、薬の種類と強さによって異なります。錠剤、カプセル、液剤、点鼻薬、点眼薬など、さまざまな形態があります。

市場力学：

抗ヒスタミン薬市場は、アレルギーの有病率の上昇、新製品の発売、革新的な製剤の承認などにより、予測期間中に大きな成長が見込まれます。例えば、2021年6月、米国食品医薬品局は、処方薬から非処方薬への部分的切り替えとして知られるプロセスを通じて、非処方薬用の鼻用抗ヒスタミン薬を承認しました。米国FDAはアステプロ（アゼラスチン塩酸塩点鼻スプレー、0.15％）を6歳以上の成人および小児の季節性および通年性アレルギー性鼻炎（アレルギーとしても知られる）に対して承認しました。

本調査の主な特徴

  • 本レポートでは、世界の抗ヒスタミン薬市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模およびCAGRを掲載しています。
  • また、異なるセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリクスを解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などの以下のパラメータに基づいて、世界の抗ヒスタミン薬市場の主要企業をプロファイルしています。
  • 本調査の対象となる主要企業には、Bayer AG、Almirall, S.A.、GlaxoSmithKline、Johnson and Johnson、Sanofi、Pfizer Inc.、Sun Pharmaceutical Industries Limited、Merck &Co.、Teva Pharmaceutical Industries Ltd.、Abbott Laboratories、Viatris Inc.、Arlak Biotech、Aden Healthcare、Sandoz Group AG、Hikma Pharmaceuticals PLC、Dr. Reddy's Laboratories、Ciplaなどが含まれます。
  • 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 世界の抗ヒスタミン薬市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界の抗ヒスタミン薬市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件

第2章 市場概要

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • 市場機会マップ

第3章 重要な洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 影響分析
  • PEST分析
  • ポーター分析
  • 技術の進歩
  • 合併、買収、コラボレーションのシナリオ
  • 最近の製品承認
  • 企業の市場シェア分析
  • 各地域の主要企業の特定
  • 輸出入分析
  • 規制シナリオ
  • 価格分析
  • 製品リコール

第4章 世界の抗ヒスタミン薬市場、薬剤クラス別、2020年～2032年

  • H-1抗ヒスタミン薬
  • 第一世代
  • 第二世代
  • H-2抗ヒスタミン薬

第5章 世界の抗ヒスタミン薬市場、形態別、2020年～2032年

  • 液体
  • タブレット
  • カプセル
  • ゲル
  • 鼻スプレー
  • その他

第6章 世界の抗ヒスタミン薬市場、適応症別、2020年～2032年

  • アレルギー疾患
  • 胃腸障害
  • 中枢神経系疾患
  • 皮膚疾患
  • その他

第7章 世界の抗ヒスタミン薬市場、投与経路別、2020年～2032年

  • 経口
  • 非経口
  • その他

第8章 世界の抗ヒスタミン薬市場、タイプ別、2020年～2032年

  • 市販薬
  • 処方箋

第9章 世界の抗ヒスタミン薬市場、流通チャネル別、2020年～2032年

  • 病院薬局
  • オンライン薬局
  • 小売薬局

第10章 世界の抗ヒスタミン薬市場、地域別、2020年～2032年

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
  • アフリカ

第11章 企業プロファイル - 世界の抗ヒスタミン薬市場

  • GlaxoSmithKline
    • 会社概要
    • 製品/サービスポートフォリオ
    • 財務実績
    • 最近の動向/アップデート
    • 戦略概要
  • Bayer AG
  • Almirall SA
  • Johnson and Johnson
  • Sanofi
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Merck &Co. Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Abbott Laboratories
  • Viatris Inc.
  • Arlak Biotech
  • Aden Healthcare
  • Sandoz Group AG
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories
  • Cipla

第12章 参考文献と調査手法

  • 参考文献
  • 調査手法
目次
Product Code: CMI6700

Global Antihistamine Drugs Market is estimated to be valued at USD 101.74 Bn in 2025 and is expected to reach USD 167.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 101.74 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.40% 2032 Value Projection: USD 167.80 Bn
Figure. Global Antihistamine Drugs Market Share (%), By Region 2025
Global Antihistamine Drugs Market - IMG1

Antihistamine drugs are a class of medications that are used to treat symptoms of allergies, such as sneezing, itching, runny nose, and watery eyes. These drugs work by blocking the action of histamine, a substance in the body that is released during an allergic reaction. There are two main types of antihistamines: First-generation antihistamines and second-generation antihistamine. Antihistamines are available over-the-counter and by prescription, depending on the specific medication and its strength. They come in various forms, including tablets, capsules, liquids, nasal sprays, and eye drops.

Market Dynamics:

The antihistamine drugs market is expected to witness significant growth over the forecast period owing to rise in the prevalence of allergies coupled, new product launches and approvals of innovative formulations. For instance, in June 2021, the U.S. Food and Drug Administration approved a nasal antihistamine for nonprescription use through a process known as a partial prescription to nonprescription switch. The U.S. FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis (also known as allergies) in adults and children aged six and older.

Key Features of the Study:

  • This report provides an in-depth analysis of the global antihistamine drugs market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global antihistamine drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Bayer AG, Almirall, S.A, GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer Inc., Sun Pharmaceutical Industries Limited, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, and Cipla
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global antihistamine drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antihistamine drugs market

Detailed Segmentation:

  • By Drug Class:
    • H-1 Antihistamines
    • First-generation
    • Second-generation
    • H-2 Antihistamines
  • By Form:
    • Liquid
    • Tablets
    • Capsules
    • Gels
    • Nasal Sprays
    • Others
  • By Indication:
    • Allergic Disorders
    • Gastrointestinal Disorders
    • Central Nervous System Disorders
    • Dermatological Disorders
    • Others
  • By Route of Administration:
    • Oral
    • Parenteral
    • Others
  • By Type:
    • OTC
    • Prescription
  • By Distribution Channel:
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Bayer AG
    • Almirall S.A
    • GlaxoSmithKline
    • Johnson and Johnson
    • Sanofi
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Limited
    • Merck & Co. Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Abbott Laboratories
    • Viatris Inc.
    • Arlak Biotech
    • Aden Healthcare
    • Sandoz Group AG
    • Hikma Pharmaceuticals PLC
    • Reddy's Laboratories
    • Cipla

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Form
    • Market Snapshot, By Indication
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancements
  • Merger, Acquisition, and Collaboration Scenario
  • Recent Product Approvals
  • Company Market Share Analysis
  • Identification of Key Players in Each Region
  • Import-Export Analysis
  • Regulatory Scenario
  • Pricing Analysis
  • Product Recalls

4. Global Antihistamine Drugs Market, By Drug Class, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • H-1 Antihistamines , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • First-generation, 2020 - 2032(US$ Billion)
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Second-generation, 2020 - 2032(US$ Billion)
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • H-2 Antihistamines , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

5. Global Antihistamine Drugs Market, By Form, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Liquid, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Tablets, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Capsules, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Gels, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Nasal Sprays, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

6. Global Antihistamine Drugs Market, By Indication, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Allergic Disorders, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Gastrointestinal Disorders, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Central Nervous System Disorders, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Dermatological Disorders, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

7. Global Antihistamine Drugs Market, By Route of Administration, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Oral, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Parenteral, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

8. Global Antihistamine Drugs Market, By Type, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • OTC, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Prescription, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

9. Global Antihistamine Drugs Market, By Distribution Channel, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Online Pharmacies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Retail Pharmacies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

10. Global Antihistamine Drugs Market, By Region, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Asean
      • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
      • South Africa
      • North Africa
      • Central Africa

11. Company Profiles - Global Antihistamine Drugs Market

  • GlaxoSmithKline *
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Bayer AG
  • Almirall S.A
  • Johnson and Johnson
  • Sanofi
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Merck & Co. Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Abbott Laboratories
  • Viatris Inc.
  • Arlak Biotech
  • Aden Healthcare
  • Sandoz Group AG
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories
  • Cipla

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact